TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8618186

Group type: EXPERIMENTAL
Intervention: Subcutaneous Epo (200 units/kg per day for 10 days)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Epo in TPN solution (200 units/kg per day for 10 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups (subcutaneous and TPN)
Number of subjects: 40
Study: 1816481

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser
Number of subjects: 70

Group type: COMPARATOR
Intervention: Scalpel
Number of subjects: 70
Study: 7100224

Group type: EXPERIMENTAL
Intervention: Cefuroxime 750 mg intravenously before and every 8 hours for the first 72 hours post-operatively
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 96
Study: 31634729

Group type: EXPERIMENTAL
Intervention: 12-month multidisciplinary program
Number of subjects: 184

Group type: COMPARATOR
Intervention: Standard antiepileptic drugs (AEDs)
Number of subjects: 184
Study: 29217600

Group type: EXPERIMENTAL
Intervention: Extra-fine beclometasone/formoterol maintenance and reliever therapy (MART)
Number of subjects: 1701

Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 1701
Study: 26149665

Group type: EXPERIMENTAL
Intervention: Childhood trauma exposure (specifically sexual assault)
Number of subjects: 1815

Group type: EXPERIMENTAL
Intervention: Childhood trauma exposure (specifically violence exposure)
Number of subjects: 1815

Group type: EXPERIMENTAL
Intervention: Low levels of childhood traumatic experiences
Number of subjects: 1815
Study: 24423311

Group type: EXPERIMENTAL
Intervention: GIP infusion (2 pmol × kg(‐1) × min(‐1))
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 12
Study: 22192096

Group type: EXPERIMENTAL
Intervention: Accordion device
Number of subjects: 21
Study: 20665055

Group type: COMPARATOR
Intervention: Ropivacaine (0.2%) alone, 0.7 ml/kg (Group R)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Ropivacaine (0.2%) plus tramadol (2 mg/kg), total volume 0.7 ml/kg (Group RT)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Ropivacaine (0.2%) alone (Group R)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Ropivacaine (0.2%) plus tramadol (2 mg/kg) (Group RT)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 44
Study: 17598014

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 20

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 20
Study: 15201783

Group type: EXPERIMENTAL
Intervention: Intravesical resiniferatoxin (0.6 microM in 50 ml of 0.9% NaCl)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Botulinum-A toxin injections (300 units diluted in 30 ml 0.9% NaCl)
Number of subjects: 25
Study: 12066012

Group type: EXPERIMENTAL
Intervention: Per-Kilo Doser (PKD)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Traditional techniques
Number of subjects: 7
Study: 9792371

Group type: EXPERIMENTAL
Intervention: 3TC (lamivudine) syrup or tablets (4 mg/kg twice daily)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: 3TC (lamivudine)
Number of subjects: 162
Study: 8694982

Group type: EXPERIMENTAL
Intervention: Electromechanical flossing device
Number of subjects: 60

Group type: COMPARATOR
Intervention: Manual flossing
Number of subjects: 60
Study: 2655691

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ibuprofen 800 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Indomethacin 50 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Frusemide
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: All treatments (Ibuprofen and Indomethacin)
Number of subjects: 8
Study: 28982

Group type: EXPERIMENTAL
Intervention: Standard electrocoagulation
Number of subjects: 300

Group type: COMPARATOR
Intervention: Tubal ring application
Number of subjects: 300
Study: 31195902

Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine system (LNG-IUS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tamoxifen treatment only (Control)
Number of subjects: 20
Study: 27571420

Group type: EXPERIMENTAL
Intervention: Idebenone
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Between-group difference favoring idebenone
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Between-group difference in IFR
Number of subjects: 64
Study: 26048780

Group type: EXPERIMENTAL
Intervention: H4:IC31 (5, 15, 50, or 150 μg with 500nmol IC31)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 24060297

Group type: EXPERIMENTAL
Intervention: Cu-IUD
Number of subjects: 200

Group type: COMPARATOR
Intervention: DMPA
Number of subjects: 200
Study: 21789287

Group type: EXPERIMENTAL
Intervention: Awareness of monitoring via implanted microsensor in the retainer
Number of subjects: 19

Group type: COMPARATOR
Intervention: Unawareness of monitoring
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Full usage of the retainer
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Misrepresentation of retainer use
Number of subjects: 19
Study: 18752926

Group type: EXPERIMENTAL
Intervention: Meat pate fortified with ferrous sulfate
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Meat pate fortified with ferric pyrophosphate encapsulated in liposomes
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Meat pate fortified with ferric pyrophosphate encapsulated in liposomes plus a hemoglobin-based meat pigment
Number of subjects: 17
Study: 16449816

Group type: EXPERIMENTAL
Intervention: Cetirizine and theophylline (200 mg twice daily)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Cetirizine and placebo
Number of subjects: 134
Study: 15006999

Group type: EXPERIMENTAL
Intervention: Tight glycemic control with GIK
Number of subjects: 141
Study: 11775650

Group type: EXPERIMENTAL
Intervention: Essaven gel (EG)
Number of subjects: 0
Study: 9265948

Group type: EXPERIMENTAL
Intervention: Mirtazapine (5-35 mg/day)
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Amitriptyline (40-280 mg/day)
Number of subjects: 580

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 580
Study: 8286256

Group type: EXPERIMENTAL
Intervention: Photochemotherapy (PUVA)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Narrow-band phototherapy (TL-01 UVB)
Number of subjects: 25
Study: 2881788

Group type: EXPERIMENTAL
Intervention: Cadralazine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 30636830

Group type: EXPERIMENTAL
Intervention: Oxaceprol 200 mg thrice daily
Number of subjects: 91

Group type: COMPARATOR
Intervention: Tramadol 50 mg thrice daily
Number of subjects: 91
Study: 26437063

Group type: EXPERIMENTAL
Intervention: Cyclosporine (CSA) with target blood concentration of 500 ng/ml
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Tacrolimus (TAC) with target blood concentration of 15 ng/ml
Number of subjects: 107
Study: 24916909

Group type: EXPERIMENTAL
Intervention: Response-adaptive randomization (RAR)
Number of subjects: 418

Group type: COMPARATOR
Intervention: Standard randomization
Number of subjects: 418
Study: 22622699

Group type: EXPERIMENTAL
Intervention: GSK+4C
Number of subjects: 1783

Group type: EXPERIMENTAL
Intervention: GSK-20C
Number of subjects: 1783

Group type: COMPARATOR
Intervention: Merck-20C
Number of subjects: 1783

Group type: EXPERIMENTAL
Intervention: GSK+4C and GSK-20C
Number of subjects: 1783
Study: 20736448

Group type: EXPERIMENTAL
Intervention: Epoetin-β (3.33×10^4 U, n=68)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo (n=70)
Number of subjects: 138
Study: 18828933

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 21
Study: 16629922

Group type: EXPERIMENTAL
Intervention: Nursing health promotion intervention (including health assessment, regular home visits or telephone contacts, health education, coordination of community services, and empowerment strategies)
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Nursing health promotion intervention
Number of subjects: 288

Group type: COMPARATOR
Intervention: Usual home care services
Number of subjects: 288
Study: 14563464

Group type: EXPERIMENTAL
Intervention: Thiocolchicoside (4 mg-2 ml) administered twice daily for 5 days
Number of subjects: 149
Study: 11063406

Group type: EXPERIMENTAL
Intervention: Noise-exposed group (bedframe workers)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Noise exposure > 90 dBA
Number of subjects: 181

Group type: COMPARATOR
Intervention: Control groups (light-metal sector and office workers)
Number of subjects: 181
Study: 9123925

Group type: EXPERIMENTAL
Intervention: Fibrin sealant as a topical haemostatic agent
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (no fibrin sealant)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Fibrin sealant
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 39
Study: 1480771

Group type: EXPERIMENTAL
Intervention: Accelerated hyperfractionation (AHF) - 42 Gy/30 F/11 days (3 F/day)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional fractionation (CF) - 50 Gy/25 F/5 weeks
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Accelerated hyperfractionation (AHF)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional fractionation (CF)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Both AHF and CF
Number of subjects: 56
Study: 6401753

Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg, by mouth)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (matching placebo)
Number of subjects: 9
Study: 30649365

Group type: EXPERIMENTAL
Intervention: Iron supplementation (42 mg elemental Fe/d)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (5 d/wk for 25 min at 75-85% of age-predicted maximum heart rate)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 30413211

Group type: EXPERIMENTAL
Intervention: Synthetic mesh (Parietene Macro™, Medtronic)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Biological implants (Permacol™, Medtronic)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 100
Study: 27054679

Group type: EXPERIMENTAL
Intervention: Three combat rations plus four 250-kcal protein-based bars (PRO, 20 g protein)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Three combat rations plus four 250-kcal carbohydrate-based bars (CHO, 48 g carbohydrate)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Three combat rations (CON)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Combined cohort (all groups)
Number of subjects: 73
Study: 24647040

Group type: EXPERIMENTAL
Intervention: Practice on a sequence of key-presses
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sleep after practice
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Verbalization of the trained sequence
Number of subjects: 80
Study: 21347864

Group type: EXPERIMENTAL
Intervention: Participants using the same response keys for all tasks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Participants using separate response keys
Number of subjects: 0
Study: 19889062

Group type: EXPERIMENTAL
Intervention: Fesoterodine 4 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fesoterodine 8 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fesoterodine 12 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18044291

Group type: EXPERIMENTAL
Intervention: ketamine 0.4 mg/kg
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: thiopental 0.5 mg/kg
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: meperidine 0.5 mg/kg
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: lidocaine 1 mg/kg
Number of subjects: 125

Group type: COMPARATOR
Intervention: saline 3 ml
Number of subjects: 125
Study: 15817615

Group type: EXPERIMENTAL
Intervention: Functional appliances (Herbst and twin block)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Headgear and passive appliances (Andresen activator and its variants)
Number of subjects: 0
Study: 12105362

Group type: EXPERIMENTAL
Intervention: Memantine 10 mg/d
Number of subjects: 321

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 321
Study: 10394155

Group type: EXPERIMENTAL
Intervention: Endovascular graft (EVG) treatment (22 patients, 14 bifurcated, 8 tube)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Traditional resection (140 patients)
Number of subjects: 162
Study: 7590615

Group type: EXPERIMENTAL
Intervention: Oral glucose load (0.75 g/kg BW per os, OGTT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intravenous glucose bolus (25 g i.v., IVGTT)
Number of subjects: 12
Study: 1791269

Group type: EXPERIMENTAL
Intervention: 400 or 2500 lux phototherapy for 2 hours on seven consecutive days
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 17
Study: 7204438

Group type: EXPERIMENTAL
Intervention: Non-surgical treatment
Number of subjects: 105

Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 105
Study: 30184105

Group type: EXPERIMENTAL
Intervention: Letrozole (5 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clomiphene citrate (CC) (100 mg)
Number of subjects: 0
Study: 29955768

Group type: EXPERIMENTAL
Intervention: pegcantratinib, 0.5% (wt/wt), applied once daily for 12 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: placebo, applied once daily for 12 weeks
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: pegcantratinib, 0.5% (wt/wt), applied once daily for 4 weeks (phase 1b)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: pegcantratinib, 0.5% (wt/wt)
Number of subjects: 15

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 15
Study: 26418489

Group type: EXPERIMENTAL
Intervention: Individualized home-based exercise program (16 weeks)
Number of subjects: 68
Study: 24279707

Group type: EXPERIMENTAL
Intervention: Sirolimus (SRL) conversion at 3 months post-transplant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cyclosporine A (CsA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CsA exposure with progression of blood pulse pressure (pp)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High 6M pulse pressure (≥ 60 mmHg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CsA maintenance
Number of subjects: 0
Study: 22799523

Group type: EXPERIMENTAL
Intervention: Estimated glomerular filtration rate (eGFR) using the MDRD equation
Number of subjects: 1239

Group type: EXPERIMENTAL
Intervention: Estimated glomerular filtration rate (eGFR) using the CKD-EPI equation
Number of subjects: 1239

Group type: EXPERIMENTAL
Intervention: Addition of eGFR by the MDRD equation to Framingham risk factors
Number of subjects: 1239
Study: 19155372

Group type: EXPERIMENTAL
Intervention: Semisynthetic penicillins (SSPs) including amoxicillin, ampicillin, pivampicillin
Number of subjects: 287

Group type: COMPARATOR
Intervention: Trimethoprim-based regimens (trimethoprim, trimethoprim-sulfamethoxazole, trimethoprim-sulfadiazine)
Number of subjects: 287
Study: 17448413

Group type: EXPERIMENTAL
Intervention: Spironolactone (20 mg daily)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 15535495

Group type: EXPERIMENTAL
Intervention: gum elastic bougie-guided technique
Number of subjects: 100

Group type: COMPARATOR
Intervention: introducer tool technique
Number of subjects: 100
Study: 11555062

Group type: EXPERIMENTAL
Intervention: Oseltamivir 75 mg once daily for 6 weeks
Number of subjects: 548
Study: 10021957

Group type: EXPERIMENTAL
Intervention: Clonidine 5 micrograms.kg‐1 po
Number of subjects: 60
Study: 8150109

Group type: EXPERIMENTAL
Intervention: Recombinant human FSH (Gonal‐F)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Urinary human FSH
Number of subjects: 12
Study: 2852485

Group type: EXPERIMENTAL
Intervention: rIFN-alpha Con1 3 MU
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: rIFN-alpha Con1 9 MU
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: rIFN-alpha Con1 30 MU
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study: 31707628

Group type: EXPERIMENTAL
Intervention: Mandibular symphysis combined with beta-tricalcium phosphate (MS+TCP)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Iliac crest (IC)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Mandibular symphysis (MS)
Number of subjects: 31
Study: 29036439

Group type: EXPERIMENTAL
Intervention: Stage tailored intervention (ST)
Number of subjects: 1243

Group type: EXPERIMENTAL
Intervention: Non-stage tailored intervention (NST)
Number of subjects: 1243

Group type: COMPARATOR
Intervention: Assessment only (AO)
Number of subjects: 1243
Study: 28160494

Group type: EXPERIMENTAL
Intervention: Midazolam 5 mg - Droperidol 5 mg
Number of subjects: 92

Group type: COMPARATOR
Intervention: Droperidol 10 mg
Number of subjects: 92

Group type: COMPARATOR
Intervention: Olanzapine 10 mg
Number of subjects: 92
Study: 23985247

Group type: EXPERIMENTAL
Intervention: Intervention group received diabetes factsheets and a DVD comprising patient stories (narratives) of type 2 diabetes management.
Number of subjects: 670

Group type: COMPARATOR
Intervention: Control group received factsheets only.
Number of subjects: 670
Study: 23303067

Group type: EXPERIMENTAL
Intervention: Attentional bias-related brain activity measured with a cocaine Stroop task in the dorsal anterior cingulate cortex (dACC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Craving in the week before treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brain activity in the dACC
Number of subjects: 0
Study: 21499196

Group type: EXPERIMENTAL
Intervention: Glutamine-enriched total parenteral nutrition (GE-TPN) solution consisting of 0.4 g/kg/day of l-alanine-glutamine dipeptide
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard total parenteral nutrition (S-TPN)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Glutamine-enriched total parenteral nutrition (GE-TPN) solution
Number of subjects: 120
Study: 18000176

Group type: EXPERIMENTAL
Intervention: 30 mg/day pioglitazone for 16 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo for 16 weeks
Number of subjects: 30
Study: 15227689

Group type: EXPERIMENTAL
Intervention: Thigh-length Medi thrombexin climax stockings
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Knee-length thrombexin climax stockings
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: Thigh-length Kendall T.E.D. stockings
Number of subjects: 376

Group type: EXPERIMENTAL
Intervention: LMWH thromboprophylaxis
Number of subjects: 376
Study: 9989513

Group type: EXPERIMENTAL
Intervention: Pion radiation therapy
Number of subjects: 217

Group type: COMPARATOR
Intervention: Conventional external beam photon therapy
Number of subjects: 217
Study: 7590426

Group type: EXPERIMENTAL
Intervention: 4 degrees C drink
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 50 degrees C drink
Number of subjects: 12

Group type: COMPARATOR
Intervention: 37 degrees C drink
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Normal saline (350 ml)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low calorie orange cordial (50 ml)
Number of subjects: 12
Study: 1713895

Group type: EXPERIMENTAL
Intervention: Autooxygenation (group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bubble oxygenator (group B)
Number of subjects: 40
Study: 449951

Group type: EXPERIMENTAL
Intervention: Amphotericin B and flucytosine combination therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Amphotericin B alone
Number of subjects: 50
Study: 31661438

Group type: EXPERIMENTAL
Intervention: Composite mesh (Ventralex Patch)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Polypropylene mesh (on-lay)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 61
Study: 28260702

Group type: EXPERIMENTAL
Intervention: Vildagliptin (50 mg) twice daily
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sitagliptin (50 mg) once daily
Number of subjects: 32
Study: 26542503

Group type: EXPERIMENTAL
Intervention: iFR-guided intervention
Number of subjects: 2000

Group type: COMPARATOR
Intervention: FFR-guided intervention
Number of subjects: 2000
Study: 24982457

Group type: EXPERIMENTAL
Intervention: Sublobar resection with brachytherapy (SRB)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Sublobar resection (SR)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Sublobar resection with brachytherapy (SRB) in patients with positive staple line cytology
Number of subjects: 222
Study: 21915042

Group type: EXPERIMENTAL
Intervention: Pelvic-floor muscle exercise (PFME) started after catheter removal post-RP
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group taught PFME in the third month after RP
Number of subjects: 62
Study: 19172346

Group type: EXPERIMENTAL
Intervention: Cuffed ePTFE grafts (Venaflo)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Noncuffed ePTFE grafts (Stretch Gore-Tex)
Number of subjects: 89
Study: 17384502

Group type: EXPERIMENTAL
Intervention: MP catheter via MP technique (group A)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Tenckhoff catheters via MP technique (group B)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Tenckhoff catheters via conventional technique (group C)
Number of subjects: 214
Study: 15193811

Group type: EXPERIMENTAL
Intervention: Thyroxine (T4) therapy
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 11208941

Group type: EXPERIMENTAL
Intervention: 400 mg of oral Lipiodol
Number of subjects: 305

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 305
Study: 9892029

Group type: EXPERIMENTAL
Intervention: CAMP education program
Number of subjects: 1041

Group type: EXPERIMENTAL
Intervention: CAMP education materials
Number of subjects: 1041
Study: 7985254

Group type: EXPERIMENTAL
Intervention: Inspiratory resistance‐positive expiratory pressure (IR‐PEP)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Positive expiratory pressure (PEP)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard chest physiotherapy (control)
Number of subjects: 160
Study: 2736096

Group type: EXPERIMENTAL
Intervention: lip shave
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: carbon dioxide laser ablation
Number of subjects: 40

Group type: COMPARATOR
Intervention: chemical peel with trichloroacetic acid
Number of subjects: 40

Group type: COMPARATOR
Intervention: topical fluorouracil
Number of subjects: 40